nodes	percent_of_prediction	percent_of_DWPC	metapath
Ruxolitinib—BMPR2—pulmonary artery—Behcet's disease	0.0235	0.039	CbGeAlD
Ruxolitinib—GRK7—eye—Behcet's disease	0.0099	0.0165	CbGeAlD
Ruxolitinib—GRK7—retina—Behcet's disease	0.00981	0.0163	CbGeAlD
Ruxolitinib—BMPR2—artery—Behcet's disease	0.00869	0.0145	CbGeAlD
Ruxolitinib—LTK—mouth—Behcet's disease	0.00853	0.0142	CbGeAlD
Ruxolitinib—GRK1—eye—Behcet's disease	0.00716	0.0119	CbGeAlD
Ruxolitinib—GRK1—retina—Behcet's disease	0.00709	0.0118	CbGeAlD
Ruxolitinib—RPS6KA6—brainstem—Behcet's disease	0.00691	0.0115	CbGeAlD
Ruxolitinib—BMPR2—blood vessel—Behcet's disease	0.00677	0.0113	CbGeAlD
Ruxolitinib—PLK1—skin of body—Behcet's disease	0.00585	0.00974	CbGeAlD
Ruxolitinib—PLK1—mammalian vulva—Behcet's disease	0.00534	0.00888	CbGeAlD
Ruxolitinib—ANKK1—nervous system—Behcet's disease	0.00487	0.0081	CbGeAlD
Ruxolitinib—JAK2—blood vessel—Behcet's disease	0.00487	0.0081	CbGeAlD
Ruxolitinib—PLK3—mammalian vulva—Behcet's disease	0.00446	0.00741	CbGeAlD
Ruxolitinib—PHKG2—brainstem—Behcet's disease	0.00429	0.00714	CbGeAlD
Ruxolitinib—PLK3—cardiac atrium—Behcet's disease	0.00427	0.0071	CbGeAlD
Ruxolitinib—CAMK1D—eye—Behcet's disease	0.00421	0.00699	CbGeAlD
Ruxolitinib—CAMK1—mammalian vulva—Behcet's disease	0.00417	0.00693	CbGeAlD
Ruxolitinib—CAMK1D—retina—Behcet's disease	0.00417	0.00693	CbGeAlD
Ruxolitinib—HIPK2—brainstem—Behcet's disease	0.00413	0.00687	CbGeAlD
Ruxolitinib—PRKG2—nervous system—Behcet's disease	0.00404	0.00671	CbGeAlD
Ruxolitinib—PRKG2—central nervous system—Behcet's disease	0.00389	0.00646	CbGeAlD
Ruxolitinib—GRK1—nervous system—Behcet's disease	0.00385	0.00641	CbGeAlD
Ruxolitinib—PRKCE—nervous system—Behcet's disease	0.00377	0.00627	CbGeAlD
Ruxolitinib—CAMK1—medulla oblongata—Behcet's disease	0.00376	0.00626	CbGeAlD
Ruxolitinib—JAK1—skin of body—Behcet's disease	0.00375	0.00623	CbGeAlD
Ruxolitinib—DYRK1A—brainstem—Behcet's disease	0.00372	0.00618	CbGeAlD
Ruxolitinib—ROCK1—eye—Behcet's disease	0.00371	0.00617	CbGeAlD
Ruxolitinib—GRK1—central nervous system—Behcet's disease	0.00371	0.00617	CbGeAlD
Ruxolitinib—BMPR2—brainstem—Behcet's disease	0.0037	0.00616	CbGeAlD
Ruxolitinib—ROCK1—retina—Behcet's disease	0.00368	0.00612	CbGeAlD
Ruxolitinib—PRKCE—central nervous system—Behcet's disease	0.00363	0.00604	CbGeAlD
Ruxolitinib—PLK1—nervous system—Behcet's disease	0.00362	0.00602	CbGeAlD
Ruxolitinib—RPS6KA6—nervous system—Behcet's disease	0.00362	0.00602	CbGeAlD
Ruxolitinib—MAST1—nervous system—Behcet's disease	0.00362	0.00602	CbGeAlD
Ruxolitinib—PLK1—central nervous system—Behcet's disease	0.00349	0.0058	CbGeAlD
Ruxolitinib—RPS6KA6—central nervous system—Behcet's disease	0.00349	0.0058	CbGeAlD
Ruxolitinib—MAST1—central nervous system—Behcet's disease	0.00349	0.0058	CbGeAlD
Ruxolitinib—DCLK3—nervous system—Behcet's disease	0.00343	0.00571	CbGeAlD
Ruxolitinib—JAK1—mammalian vulva—Behcet's disease	0.00342	0.00569	CbGeAlD
Ruxolitinib—DCLK1—mammalian vulva—Behcet's disease	0.00342	0.00569	CbGeAlD
Ruxolitinib—CAMK1—spinal cord—Behcet's disease	0.00336	0.00558	CbGeAlD
Ruxolitinib—CAMK1D—mammalian vulva—Behcet's disease	0.00334	0.00555	CbGeAlD
Ruxolitinib—CAMK2G—brainstem—Behcet's disease	0.00331	0.00551	CbGeAlD
Ruxolitinib—DCLK3—central nervous system—Behcet's disease	0.00331	0.0055	CbGeAlD
Ruxolitinib—LRRK2—brainstem—Behcet's disease	0.00328	0.00546	CbGeAlD
Ruxolitinib—JAK1—cardiac atrium—Behcet's disease	0.00327	0.00544	CbGeAlD
Ruxolitinib—DAPK2—mammalian vulva—Behcet's disease	0.00326	0.00542	CbGeAlD
Ruxolitinib—CAMK2G—eye—Behcet's disease	0.00323	0.00536	CbGeAlD
Ruxolitinib—CAMK1D—cardiac atrium—Behcet's disease	0.0032	0.00531	CbGeAlD
Ruxolitinib—BMPR2—skin of body—Behcet's disease	0.00314	0.00521	CbGeAlD
Ruxolitinib—DAPK2—cardiac atrium—Behcet's disease	0.00312	0.00519	CbGeAlD
Ruxolitinib—JAK1—medulla oblongata—Behcet's disease	0.00309	0.00513	CbGeAlD
Ruxolitinib—DCLK1—medulla oblongata—Behcet's disease	0.00309	0.00513	CbGeAlD
Ruxolitinib—PRKG2—brain—Behcet's disease	0.00309	0.00513	CbGeAlD
Ruxolitinib—DAPK3—mammalian vulva—Behcet's disease	0.00307	0.0051	CbGeAlD
Ruxolitinib—CLK2—mammalian vulva—Behcet's disease	0.00304	0.00505	CbGeAlD
Ruxolitinib—PLK3—nervous system—Behcet's disease	0.00302	0.00503	CbGeAlD
Ruxolitinib—CAMK1D—medulla oblongata—Behcet's disease	0.00301	0.00501	CbGeAlD
Ruxolitinib—PHKG2—medulla oblongata—Behcet's disease	0.00299	0.00498	CbGeAlD
Ruxolitinib—DAPK2—medulla oblongata—Behcet's disease	0.00294	0.0049	CbGeAlD
Ruxolitinib—GRK1—brain—Behcet's disease	0.00294	0.0049	CbGeAlD
Ruxolitinib—DAPK3—cardiac atrium—Behcet's disease	0.00294	0.00488	CbGeAlD
Ruxolitinib—PLK3—central nervous system—Behcet's disease	0.00291	0.00484	CbGeAlD
Ruxolitinib—CLK2—cardiac atrium—Behcet's disease	0.00291	0.00484	CbGeAlD
Ruxolitinib—PRKCE—brain—Behcet's disease	0.00288	0.00479	CbGeAlD
Ruxolitinib—MAP3K7—retina—Behcet's disease	0.00288	0.00478	CbGeAlD
Ruxolitinib—TYK2—eye—Behcet's disease	0.00285	0.00474	CbGeAlD
Ruxolitinib—CAMK1—nervous system—Behcet's disease	0.00283	0.0047	CbGeAlD
Ruxolitinib—TYK2—retina—Behcet's disease	0.00282	0.0047	CbGeAlD
Ruxolitinib—JAK1—midbrain—Behcet's disease	0.00282	0.00469	CbGeAlD
Ruxolitinib—DCLK1—midbrain—Behcet's disease	0.00282	0.00469	CbGeAlD
Ruxolitinib—MKNK2—eye—Behcet's disease	0.00281	0.00468	CbGeAlD
Ruxolitinib—MKNK2—retina—Behcet's disease	0.00279	0.00463	CbGeAlD
Ruxolitinib—DAPK3—medulla oblongata—Behcet's disease	0.00277	0.0046	CbGeAlD
Ruxolitinib—RPS6KA6—brain—Behcet's disease	0.00277	0.0046	CbGeAlD
Ruxolitinib—PLK1—brain—Behcet's disease	0.00277	0.0046	CbGeAlD
Ruxolitinib—MAST1—brain—Behcet's disease	0.00277	0.0046	CbGeAlD
Ruxolitinib—JAK1—spinal cord—Behcet's disease	0.00275	0.00458	CbGeAlD
Ruxolitinib—DCLK1—spinal cord—Behcet's disease	0.00275	0.00458	CbGeAlD
Ruxolitinib—MARK2—nervous system—Behcet's disease	0.00274	0.00456	CbGeAlD
Ruxolitinib—BMPR2—cardiac atrium—Behcet's disease	0.00274	0.00455	CbGeAlD
Ruxolitinib—NUAK2—mammalian vulva—Behcet's disease	0.00273	0.00455	CbGeAlD
Ruxolitinib—CAMK1—central nervous system—Behcet's disease	0.00272	0.00453	CbGeAlD
Ruxolitinib—DAPK2—midbrain—Behcet's disease	0.00269	0.00448	CbGeAlD
Ruxolitinib—MARK2—central nervous system—Behcet's disease	0.00264	0.00439	CbGeAlD
Ruxolitinib—DAPK2—spinal cord—Behcet's disease	0.00263	0.00437	CbGeAlD
Ruxolitinib—DCLK3—brain—Behcet's disease	0.00262	0.00436	CbGeAlD
Ruxolitinib—BMPR2—medulla oblongata—Behcet's disease	0.00258	0.00429	CbGeAlD
Ruxolitinib—HIPK2—spinal cord—Behcet's disease	0.00257	0.00427	CbGeAlD
Ruxolitinib—LRRK2—mammalian vulva—Behcet's disease	0.00254	0.00422	CbGeAlD
Ruxolitinib—DAPK3—midbrain—Behcet's disease	0.00253	0.00421	CbGeAlD
Ruxolitinib—TYK2—skin of body—Behcet's disease	0.00248	0.00412	CbGeAlD
Ruxolitinib—DAPK3—spinal cord—Behcet's disease	0.00247	0.00411	CbGeAlD
Ruxolitinib—BMPR2—midbrain—Behcet's disease	0.00236	0.00392	CbGeAlD
Ruxolitinib—TAOK3—brainstem—Behcet's disease	0.00234	0.00389	CbGeAlD
Ruxolitinib—JAK3—nervous system—Behcet's disease	0.00233	0.00388	CbGeAlD
Ruxolitinib—JAK1—nervous system—Behcet's disease	0.00232	0.00386	CbGeAlD
Ruxolitinib—DCLK1—nervous system—Behcet's disease	0.00232	0.00386	CbGeAlD
Ruxolitinib—CAMK2G—medulla oblongata—Behcet's disease	0.00231	0.00384	CbGeAlD
Ruxolitinib—PLK3—brain—Behcet's disease	0.00231	0.00384	CbGeAlD
Ruxolitinib—MAP3K7—mammalian vulva—Behcet's disease	0.0023	0.00383	CbGeAlD
Ruxolitinib—LRRK2—medulla oblongata—Behcet's disease	0.00229	0.00381	CbGeAlD
Ruxolitinib—TAOK3—eye—Behcet's disease	0.00228	0.00379	CbGeAlD
Ruxolitinib—CAMK1D—nervous system—Behcet's disease	0.00226	0.00376	CbGeAlD
Ruxolitinib—TYK2—mammalian vulva—Behcet's disease	0.00226	0.00376	CbGeAlD
Ruxolitinib—TAOK3—retina—Behcet's disease	0.00226	0.00375	CbGeAlD
Ruxolitinib—JAK2—skin of body—Behcet's disease	0.00226	0.00375	CbGeAlD
Ruxolitinib—PHKG2—nervous system—Behcet's disease	0.00225	0.00374	CbGeAlD
Ruxolitinib—JAK3—central nervous system—Behcet's disease	0.00225	0.00374	CbGeAlD
Ruxolitinib—JAK1—central nervous system—Behcet's disease	0.00223	0.00371	CbGeAlD
Ruxolitinib—DCLK1—central nervous system—Behcet's disease	0.00223	0.00371	CbGeAlD
Ruxolitinib—LTK—brain—Behcet's disease	0.00223	0.00371	CbGeAlD
Ruxolitinib—IRAK1—mammalian vulva—Behcet's disease	0.00223	0.00371	CbGeAlD
Ruxolitinib—MKNK2—mammalian vulva—Behcet's disease	0.00223	0.00371	CbGeAlD
Ruxolitinib—MAP3K7—cardiac atrium—Behcet's disease	0.0022	0.00367	CbGeAlD
Ruxolitinib—CAMK1D—central nervous system—Behcet's disease	0.00218	0.00362	CbGeAlD
Ruxolitinib—STK16—nervous system—Behcet's disease	0.00218	0.00362	CbGeAlD
Ruxolitinib—MAP3K3—skin of body—Behcet's disease	0.00217	0.00361	CbGeAlD
Ruxolitinib—PHKG2—central nervous system—Behcet's disease	0.00217	0.0036	CbGeAlD
Ruxolitinib—HIPK2—nervous system—Behcet's disease	0.00216	0.0036	CbGeAlD
Ruxolitinib—TYK2—cardiac atrium—Behcet's disease	0.00216	0.0036	CbGeAlD
Ruxolitinib—CAMK1—brain—Behcet's disease	0.00216	0.00359	CbGeAlD
Ruxolitinib—MKNK2—cardiac atrium—Behcet's disease	0.00214	0.00355	CbGeAlD
Ruxolitinib—MAP3K19—nervous system—Behcet's disease	0.00212	0.00353	CbGeAlD
Ruxolitinib—CAMK2G—midbrain—Behcet's disease	0.00211	0.00351	CbGeAlD
Ruxolitinib—BMP2K—midbrain—Behcet's disease	0.00211	0.00351	CbGeAlD
Ruxolitinib—MARK2—brain—Behcet's disease	0.0021	0.00349	CbGeAlD
Ruxolitinib—STK16—central nervous system—Behcet's disease	0.0021	0.00348	CbGeAlD
Ruxolitinib—LRRK2—midbrain—Behcet's disease	0.00209	0.00348	CbGeAlD
Ruxolitinib—HIPK2—central nervous system—Behcet's disease	0.00208	0.00347	CbGeAlD
Ruxolitinib—DAPK3—nervous system—Behcet's disease	0.00208	0.00346	CbGeAlD
Ruxolitinib—MAP3K7—medulla oblongata—Behcet's disease	0.00208	0.00346	CbGeAlD
Ruxolitinib—CLK2—nervous system—Behcet's disease	0.00206	0.00343	CbGeAlD
Ruxolitinib—BMP2K—spinal cord—Behcet's disease	0.00206	0.00343	CbGeAlD
Ruxolitinib—CAMK2G—spinal cord—Behcet's disease	0.00206	0.00343	CbGeAlD
Ruxolitinib—JAK2—mammalian vulva—Behcet's disease	0.00206	0.00342	CbGeAlD
Ruxolitinib—MAP3K19—central nervous system—Behcet's disease	0.00204	0.0034	CbGeAlD
Ruxolitinib—LRRK2—spinal cord—Behcet's disease	0.00204	0.0034	CbGeAlD
Ruxolitinib—TYK2—medulla oblongata—Behcet's disease	0.00204	0.00339	CbGeAlD
Ruxolitinib—MKNK2—medulla oblongata—Behcet's disease	0.00201	0.00335	CbGeAlD
Ruxolitinib—DAPK3—central nervous system—Behcet's disease	0.002	0.00333	CbGeAlD
Ruxolitinib—ROCK1—nervous system—Behcet's disease	0.002	0.00332	CbGeAlD
Ruxolitinib—CLK2—central nervous system—Behcet's disease	0.00198	0.0033	CbGeAlD
Ruxolitinib—MAP3K3—mammalian vulva—Behcet's disease	0.00198	0.0033	CbGeAlD
Ruxolitinib—JAK2—cardiac atrium—Behcet's disease	0.00197	0.00328	CbGeAlD
Ruxolitinib—RET—medulla oblongata—Behcet's disease	0.00196	0.00327	CbGeAlD
Ruxolitinib—DYRK1A—nervous system—Behcet's disease	0.00195	0.00324	CbGeAlD
Ruxolitinib—TAOK2—brain—Behcet's disease	0.00194	0.00323	CbGeAlD
Ruxolitinib—BMPR2—nervous system—Behcet's disease	0.00194	0.00323	CbGeAlD
Ruxolitinib—ROCK1—central nervous system—Behcet's disease	0.00192	0.0032	CbGeAlD
Ruxolitinib—MAP3K7—midbrain—Behcet's disease	0.0019	0.00316	CbGeAlD
Ruxolitinib—MAP3K3—cardiac atrium—Behcet's disease	0.0019	0.00316	CbGeAlD
Ruxolitinib—DYRK1A—central nervous system—Behcet's disease	0.00188	0.00312	CbGeAlD
Ruxolitinib—BMPR2—central nervous system—Behcet's disease	0.00187	0.00311	CbGeAlD
Ruxolitinib—TYK2—midbrain—Behcet's disease	0.00187	0.0031	CbGeAlD
Ruxolitinib—JAK2—medulla oblongata—Behcet's disease	0.00186	0.00309	CbGeAlD
Ruxolitinib—MAP3K7—spinal cord—Behcet's disease	0.00185	0.00308	CbGeAlD
Ruxolitinib—MKNK2—midbrain—Behcet's disease	0.00184	0.00306	CbGeAlD
Ruxolitinib—IRAK1—midbrain—Behcet's disease	0.00184	0.00306	CbGeAlD
Ruxolitinib—TYK2—spinal cord—Behcet's disease	0.00182	0.00303	CbGeAlD
Ruxolitinib—TAOK3—mammalian vulva—Behcet's disease	0.00181	0.00301	CbGeAlD
Ruxolitinib—MKNK2—spinal cord—Behcet's disease	0.0018	0.00299	CbGeAlD
Ruxolitinib—RET—midbrain—Behcet's disease	0.0018	0.00299	CbGeAlD
Ruxolitinib—MAP3K3—medulla oblongata—Behcet's disease	0.00179	0.00298	CbGeAlD
Ruxolitinib—JAK3—brain—Behcet's disease	0.00178	0.00297	CbGeAlD
Ruxolitinib—JAK1—brain—Behcet's disease	0.00177	0.00295	CbGeAlD
Ruxolitinib—DCLK1—brain—Behcet's disease	0.00177	0.00295	CbGeAlD
Ruxolitinib—PLK4—brain—Behcet's disease	0.00176	0.00293	CbGeAlD
Ruxolitinib—RET—spinal cord—Behcet's disease	0.00175	0.00291	CbGeAlD
Ruxolitinib—CAMK2G—nervous system—Behcet's disease	0.00174	0.00289	CbGeAlD
Ruxolitinib—BMP2K—nervous system—Behcet's disease	0.00174	0.00289	CbGeAlD
Ruxolitinib—TAOK3—cardiac atrium—Behcet's disease	0.00173	0.00288	CbGeAlD
Ruxolitinib—CAMK1D—brain—Behcet's disease	0.00173	0.00288	CbGeAlD
Ruxolitinib—LRRK2—nervous system—Behcet's disease	0.00172	0.00286	CbGeAlD
Ruxolitinib—PHKG2—brain—Behcet's disease	0.00172	0.00286	CbGeAlD
Ruxolitinib—DAPK2—brain—Behcet's disease	0.00169	0.00281	CbGeAlD
Ruxolitinib—CAMK2G—central nervous system—Behcet's disease	0.00167	0.00278	CbGeAlD
Ruxolitinib—BMP2K—central nervous system—Behcet's disease	0.00167	0.00278	CbGeAlD
Ruxolitinib—STK16—brain—Behcet's disease	0.00166	0.00277	CbGeAlD
Ruxolitinib—LRRK2—central nervous system—Behcet's disease	0.00166	0.00275	CbGeAlD
Ruxolitinib—JAK2—spinal cord—Behcet's disease	0.00166	0.00275	CbGeAlD
Ruxolitinib—HIPK2—brain—Behcet's disease	0.00165	0.00275	CbGeAlD
Ruxolitinib—MAP3K3—midbrain—Behcet's disease	0.00164	0.00272	CbGeAlD
Ruxolitinib—TAOK3—medulla oblongata—Behcet's disease	0.00163	0.00271	CbGeAlD
Ruxolitinib—MAP3K19—brain—Behcet's disease	0.00162	0.0027	CbGeAlD
Ruxolitinib—MAP3K3—spinal cord—Behcet's disease	0.0016	0.00265	CbGeAlD
Ruxolitinib—DAPK3—brain—Behcet's disease	0.00159	0.00264	CbGeAlD
Ruxolitinib—MAP3K2—nervous system—Behcet's disease	0.00158	0.00262	CbGeAlD
Ruxolitinib—CLK2—brain—Behcet's disease	0.00157	0.00262	CbGeAlD
Ruxolitinib—TYK2—nervous system—Behcet's disease	0.00153	0.00255	CbGeAlD
Ruxolitinib—ROCK1—brain—Behcet's disease	0.00153	0.00254	CbGeAlD
Ruxolitinib—MAP3K2—central nervous system—Behcet's disease	0.00152	0.00252	CbGeAlD
Ruxolitinib—MKNK2—nervous system—Behcet's disease	0.00151	0.00252	CbGeAlD
Ruxolitinib—TAOK3—midbrain—Behcet's disease	0.00149	0.00248	CbGeAlD
Ruxolitinib—DYRK1A—brain—Behcet's disease	0.00149	0.00248	CbGeAlD
Ruxolitinib—BMPR2—brain—Behcet's disease	0.00148	0.00247	CbGeAlD
Ruxolitinib—TYK2—central nervous system—Behcet's disease	0.00148	0.00246	CbGeAlD
Ruxolitinib—RET—nervous system—Behcet's disease	0.00148	0.00245	CbGeAlD
Ruxolitinib—MKNK2—central nervous system—Behcet's disease	0.00146	0.00242	CbGeAlD
Ruxolitinib—TAOK3—spinal cord—Behcet's disease	0.00145	0.00242	CbGeAlD
Ruxolitinib—RET—central nervous system—Behcet's disease	0.00142	0.00236	CbGeAlD
Ruxolitinib—NUAK2—brain—Behcet's disease	0.00142	0.00236	CbGeAlD
Ruxolitinib—JAK2—nervous system—Behcet's disease	0.0014	0.00232	CbGeAlD
Ruxolitinib—MAP3K3—nervous system—Behcet's disease	0.00134	0.00224	CbGeAlD
Ruxolitinib—JAK2—central nervous system—Behcet's disease	0.00134	0.00223	CbGeAlD
Ruxolitinib—BMP2K—brain—Behcet's disease	0.00133	0.00221	CbGeAlD
Ruxolitinib—CAMK2G—brain—Behcet's disease	0.00133	0.00221	CbGeAlD
Ruxolitinib—LRRK2—brain—Behcet's disease	0.00131	0.00219	CbGeAlD
Ruxolitinib—MAP3K3—central nervous system—Behcet's disease	0.00129	0.00215	CbGeAlD
Ruxolitinib—TAOK3—nervous system—Behcet's disease	0.00123	0.00204	CbGeAlD
Ruxolitinib—MAP3K2—brain—Behcet's disease	0.0012	0.002	CbGeAlD
Ruxolitinib—MAP3K7—brain—Behcet's disease	0.00119	0.00198	CbGeAlD
Ruxolitinib—TAOK3—central nervous system—Behcet's disease	0.00118	0.00196	CbGeAlD
Ruxolitinib—TYK2—brain—Behcet's disease	0.00117	0.00195	CbGeAlD
Ruxolitinib—MKNK2—brain—Behcet's disease	0.00116	0.00192	CbGeAlD
Ruxolitinib—IRAK1—brain—Behcet's disease	0.00116	0.00192	CbGeAlD
Ruxolitinib—RET—brain—Behcet's disease	0.00113	0.00188	CbGeAlD
Ruxolitinib—JAK2—brain—Behcet's disease	0.00107	0.00177	CbGeAlD
Ruxolitinib—MAP3K3—brain—Behcet's disease	0.00103	0.00171	CbGeAlD
Ruxolitinib—TAOK3—brain—Behcet's disease	0.000937	0.00156	CbGeAlD
Ruxolitinib—JAK1—Cytokine Signaling in Immune system—HLA-B—Behcet's disease	0.000536	0.00134	CbGpPWpGaD
Ruxolitinib—ROCK1—EGF/EGFR Signaling Pathway—NOS3—Behcet's disease	0.000529	0.00133	CbGpPWpGaD
Ruxolitinib—IRAK1—Toll-like Receptor Signaling Pathway—CXCL8—Behcet's disease	0.000525	0.00132	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—ITGB2—Behcet's disease	0.000525	0.00132	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by VEGF—NOS3—Behcet's disease	0.000522	0.00131	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—ERAP1—Behcet's disease	0.000515	0.00129	CbGpPWpGaD
Ruxolitinib—JAK3—Platelet activation, signaling and aggregation—SERPINE1—Behcet's disease	0.000511	0.00128	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—CCR1—Behcet's disease	0.00051	0.00128	CbGpPWpGaD
Ruxolitinib—JAK3—Cytokine Signaling in Immune system—ICAM1—Behcet's disease	0.000506	0.00127	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—ITGB2—Behcet's disease	0.000498	0.00125	CbGpPWpGaD
Ruxolitinib—PRKCE—Hemostasis—APOB—Behcet's disease	0.000497	0.00125	CbGpPWpGaD
Ruxolitinib—MAP3K7—Toll-like Receptor Signaling Pathway—CXCL8—Behcet's disease	0.000495	0.00124	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—ITGB2—Behcet's disease	0.000483	0.00121	CbGpPWpGaD
Ruxolitinib—JAK1—GPCR downstream signaling—CCR1—Behcet's disease	0.000483	0.00121	CbGpPWpGaD
Ruxolitinib—TYK2—Interferon Signaling—ICAM1—Behcet's disease	0.000481	0.00121	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—ITGB2—Behcet's disease	0.000481	0.00121	CbGpPWpGaD
Ruxolitinib—ROCK1—GPCR downstream signaling—CCR1—Behcet's disease	0.000475	0.00119	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—ITGAL—Behcet's disease	0.000474	0.00119	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—ITGB2—Behcet's disease	0.00047	0.00118	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—ITGB2—Behcet's disease	0.000469	0.00118	CbGpPWpGaD
Ruxolitinib—MAP3K2—MAPK Signaling Pathway—TNF—Behcet's disease	0.000462	0.00116	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—ITGB2—Behcet's disease	0.00045	0.00113	CbGpPWpGaD
Ruxolitinib—JAK2—Interferon Signaling—HLA-B—Behcet's disease	0.000449	0.00113	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—ITGB2—Behcet's disease	0.000443	0.00111	CbGpPWpGaD
Ruxolitinib—PLK1—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	0.00044	0.0011	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—MEFV—Behcet's disease	0.00044	0.0011	CbGpPWpGaD
Ruxolitinib—JAK1—Platelet activation, signaling and aggregation—SERPINE1—Behcet's disease	0.00044	0.0011	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—CCR1—Behcet's disease	0.000439	0.0011	CbGpPWpGaD
Ruxolitinib—JAK1—Cytokine Signaling in Immune system—ICAM1—Behcet's disease	0.000435	0.00109	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—ITGAL—Behcet's disease	0.000434	0.00109	CbGpPWpGaD
Ruxolitinib—JAK2—DAP12 interactions—HLA-B—Behcet's disease	0.000433	0.00109	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—CCR1—Behcet's disease	0.000431	0.00108	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—MEFV—Behcet's disease	0.000427	0.00107	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—ITGAL—Behcet's disease	0.000424	0.00106	CbGpPWpGaD
Ruxolitinib—JAK2—VEGFA-VEGFR2 Pathway—NOS3—Behcet's disease	0.000419	0.00105	CbGpPWpGaD
Ruxolitinib—JAK3—Hemostasis—APOB—Behcet's disease	0.000419	0.00105	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—MEFV—Behcet's disease	0.000414	0.00104	CbGpPWpGaD
Ruxolitinib—PRKCE—Innate Immune System—HLA-B—Behcet's disease	0.000414	0.00104	CbGpPWpGaD
Ruxolitinib—IRAK1—Regulation of toll-like receptor signaling pathway—CXCL8—Behcet's disease	0.00041	0.00103	CbGpPWpGaD
Ruxolitinib—GRK1—Disease—APOB—Behcet's disease	0.00041	0.00103	CbGpPWpGaD
Ruxolitinib—IRAK1—Cytokine Signaling in Immune system—HLA-B—Behcet's disease	0.000408	0.00102	CbGpPWpGaD
Ruxolitinib—CAMK2G—Cellular responses to stress—CXCL8—Behcet's disease	0.000407	0.00102	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—ITGB2—Behcet's disease	0.000407	0.00102	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—ITGAL—Behcet's disease	0.000406	0.00102	CbGpPWpGaD
Ruxolitinib—CYP3A4—Tryptophan metabolism—CAT—Behcet's disease	0.0004	0.001	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—ITGAL—Behcet's disease	0.0004	0.001	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by VEGF—NOS3—Behcet's disease	0.000396	0.000993	CbGpPWpGaD
Ruxolitinib—TYK2—Cytokine Signaling in Immune system—HLA-B—Behcet's disease	0.000396	0.000992	CbGpPWpGaD
Ruxolitinib—PRKCE—Hemostasis—APOA1—Behcet's disease	0.000393	0.000986	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—ERAP1—Behcet's disease	0.000392	0.000983	CbGpPWpGaD
Ruxolitinib—MAP3K7—Regulation of toll-like receptor signaling pathway—CXCL8—Behcet's disease	0.000386	0.000969	CbGpPWpGaD
Ruxolitinib—MAP3K7—Cytokine Signaling in Immune system—HLA-B—Behcet's disease	0.000384	0.000962	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—ITGB2—Behcet's disease	0.000381	0.000956	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—ERAP1—Behcet's disease	0.00038	0.000954	CbGpPWpGaD
Ruxolitinib—PRKG2—Metabolism—CAT—Behcet's disease	0.000376	0.000943	CbGpPWpGaD
Ruxolitinib—MAP3K7—TNF alpha Signaling Pathway—TNF—Behcet's disease	0.000374	0.000938	CbGpPWpGaD
Ruxolitinib—CYP3A4—nervous system—Behcet's disease	0.000372	0.000619	CbGeAlD
Ruxolitinib—PHKG2—Disease—APOB—Behcet's disease	0.000371	0.000929	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—ERAP1—Behcet's disease	0.000369	0.000925	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—ITGAL—Behcet's disease	0.000367	0.00092	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—ITGB2—Behcet's disease	0.000366	0.000918	CbGpPWpGaD
Ruxolitinib—IRAK1—Toll-like Receptor Signaling Pathway—TNF—Behcet's disease	0.000366	0.000917	CbGpPWpGaD
Ruxolitinib—PRKG2—Metabolism—APOB—Behcet's disease	0.000365	0.000915	CbGpPWpGaD
Ruxolitinib—JAK2—Interferon Signaling—ICAM1—Behcet's disease	0.000365	0.000915	CbGpPWpGaD
Ruxolitinib—JAK1—Hemostasis—APOB—Behcet's disease	0.000361	0.000905	CbGpPWpGaD
Ruxolitinib—CYP3A4—central nervous system—Behcet's disease	0.000359	0.000596	CbGeAlD
Ruxolitinib—PRKCE—Signaling Pathways—CCR1—Behcet's disease	0.000357	0.000895	CbGpPWpGaD
Ruxolitinib—MAP3K7—Toll-like Receptor Signaling Pathway—TNF—Behcet's disease	0.000344	0.000864	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—ITGAL—Behcet's disease	0.000344	0.000862	CbGpPWpGaD
Ruxolitinib—ROCK1—Apoptosis—TNF—Behcet's disease	0.000338	0.000849	CbGpPWpGaD
Ruxolitinib—JAK3—Hemostasis—APOA1—Behcet's disease	0.000332	0.000832	CbGpPWpGaD
Ruxolitinib—IRAK1—Cytokine Signaling in Immune system—ICAM1—Behcet's disease	0.000331	0.00083	CbGpPWpGaD
Ruxolitinib—RPS6KA6—Developmental Biology—TNF—Behcet's disease	0.000329	0.000825	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—CTLA4—Behcet's disease	0.000326	0.000817	CbGpPWpGaD
Ruxolitinib—GRK1—Disease—APOA1—Behcet's disease	0.000324	0.000813	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—CCR1—Behcet's disease	0.000324	0.000812	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—MEFV—Behcet's disease	0.000323	0.000811	CbGpPWpGaD
Ruxolitinib—TYK2—Cytokine Signaling in Immune system—ICAM1—Behcet's disease	0.000321	0.000806	CbGpPWpGaD
Ruxolitinib—PHKG2—Metabolism—CAT—Behcet's disease	0.00032	0.000802	CbGpPWpGaD
Ruxolitinib—PRKCE—Hemostasis—SERPINE1—Behcet's disease	0.000312	0.000783	CbGpPWpGaD
Ruxolitinib—MAP3K7—Cytokine Signaling in Immune system—ICAM1—Behcet's disease	0.000312	0.000782	CbGpPWpGaD
Ruxolitinib—PHKG2—Metabolism—APOB—Behcet's disease	0.00031	0.000778	CbGpPWpGaD
Ruxolitinib—JAK2—Platelet activation, signaling and aggregation—APOA1—Behcet's disease	0.00031	0.000777	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—APOB—Behcet's disease	0.000305	0.000765	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—CCR1—Behcet's disease	0.000301	0.000755	CbGpPWpGaD
Ruxolitinib—JAK2—EGF/EGFR Signaling Pathway—NOS3—Behcet's disease	0.000301	0.000755	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—HLA-B—Behcet's disease	0.000301	0.000754	CbGpPWpGaD
Ruxolitinib—JAK2—Cytokine Signaling in Immune system—HLA-B—Behcet's disease	0.0003	0.000752	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—CTLA4—Behcet's disease	0.000299	0.000749	CbGpPWpGaD
Ruxolitinib—PRKCE—Hemostasis—NOS3—Behcet's disease	0.000298	0.000747	CbGpPWpGaD
Ruxolitinib—HIPK2—Gene Expression—SERPINE1—Behcet's disease	0.000295	0.000739	CbGpPWpGaD
Ruxolitinib—PHKG2—Disease—APOA1—Behcet's disease	0.000293	0.000735	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—CTLA4—Behcet's disease	0.000292	0.000731	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—ITGB2—Behcet's disease	0.00029	0.000727	CbGpPWpGaD
Ruxolitinib—PRKG2—Metabolism—APOA1—Behcet's disease	0.000289	0.000724	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—ERAP1—Behcet's disease	0.000288	0.000723	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—APOB—Behcet's disease	0.000287	0.00072	CbGpPWpGaD
Ruxolitinib—IRAK1—Regulation of toll-like receptor signaling pathway—TNF—Behcet's disease	0.000286	0.000716	CbGpPWpGaD
Ruxolitinib—JAK1—Hemostasis—APOA1—Behcet's disease	0.000285	0.000716	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—ITGB2—Behcet's disease	0.000281	0.000706	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—CTLA4—Behcet's disease	0.000279	0.000701	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—CTLA4—Behcet's disease	0.000275	0.00069	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—ITGB2—Behcet's disease	0.000273	0.000685	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—CCR1—Behcet's disease	0.00027	0.000678	CbGpPWpGaD
Ruxolitinib—MAP3K7—Regulation of toll-like receptor signaling pathway—TNF—Behcet's disease	0.000269	0.000674	CbGpPWpGaD
Ruxolitinib—JAK3—Hemostasis—SERPINE1—Behcet's disease	0.000263	0.000661	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—ITGAL—Behcet's disease	0.000261	0.000656	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—APOB—Behcet's disease	0.000259	0.000651	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—CCR1—Behcet's disease	0.000259	0.00065	CbGpPWpGaD
Ruxolitinib—GRK1—Disease—SERPINE1—Behcet's disease	0.000257	0.000645	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—CCR1—Behcet's disease	0.000255	0.000639	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—ITGAL—Behcet's disease	0.000254	0.000637	CbGpPWpGaD
Ruxolitinib—JAK3—Hemostasis—NOS3—Behcet's disease	0.000251	0.000631	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—ITGAL—Behcet's disease	0.000246	0.000617	CbGpPWpGaD
Ruxolitinib—JAK2—Platelet activation, signaling and aggregation—SERPINE1—Behcet's disease	0.000246	0.000617	CbGpPWpGaD
Ruxolitinib—GRK1—Disease—NOS3—Behcet's disease	0.000246	0.000616	CbGpPWpGaD
Ruxolitinib—PHKG2—Metabolism—APOA1—Behcet's disease	0.000246	0.000616	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—CCR1—Behcet's disease	0.000245	0.000615	CbGpPWpGaD
Ruxolitinib—JAK2—Cytokine Signaling in Immune system—ICAM1—Behcet's disease	0.000244	0.000611	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—APOA1—Behcet's disease	0.000241	0.000606	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—HLA-B—Behcet's disease	0.000241	0.000605	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—APOB—Behcet's disease	0.000241	0.000603	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—CTLA4—Behcet's disease	0.000237	0.000593	CbGpPWpGaD
Ruxolitinib—PHKG2—Disease—SERPINE1—Behcet's disease	0.000233	0.000584	CbGpPWpGaD
Ruxolitinib—MAP3K7—MAPK Signaling Pathway—TNF—Behcet's disease	0.000231	0.000579	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—HLA-B—Behcet's disease	0.000229	0.000573	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—APOA1—Behcet's disease	0.000227	0.000569	CbGpPWpGaD
Ruxolitinib—JAK1—Hemostasis—SERPINE1—Behcet's disease	0.000227	0.000568	CbGpPWpGaD
Ruxolitinib—PHKG2—Disease—NOS3—Behcet's disease	0.000222	0.000557	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—HLA-B—Behcet's disease	0.000222	0.000556	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—HLA-B—Behcet's disease	0.000221	0.000554	CbGpPWpGaD
Ruxolitinib—PRKG2—Metabolism—NOS3—Behcet's disease	0.000219	0.000549	CbGpPWpGaD
Ruxolitinib—JAK1—Hemostasis—NOS3—Behcet's disease	0.000216	0.000543	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—HLA-B—Behcet's disease	0.000216	0.000541	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—HLA-B—Behcet's disease	0.000215	0.00054	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—ITGB2—Behcet's disease	0.000213	0.000535	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—HLA-B—Behcet's disease	0.000207	0.000518	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—APOA1—Behcet's disease	0.000205	0.000515	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—HLA-B—Behcet's disease	0.000203	0.00051	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—APOB—Behcet's disease	0.000202	0.000506	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—CCR1—Behcet's disease	0.000197	0.000494	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—ICAM1—Behcet's disease	0.000196	0.000491	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—ITGAL—Behcet's disease	0.000192	0.000482	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—SERPINE1—Behcet's disease	0.000192	0.000481	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CCR1—Behcet's disease	0.000191	0.00048	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—APOA1—Behcet's disease	0.00019	0.000477	CbGpPWpGaD
Ruxolitinib—PHKG2—Metabolism—NOS3—Behcet's disease	0.000186	0.000467	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CCR1—Behcet's disease	0.000186	0.000465	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—NOS3—Behcet's disease	0.000183	0.000459	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—SERPINE1—Behcet's disease	0.00018	0.000452	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—CTLA4—Behcet's disease	0.00018	0.000451	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—ICAM1—Behcet's disease	0.000179	0.00045	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—ICAM1—Behcet's disease	0.000175	0.00044	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—HLA-B—Behcet's disease	0.000175	0.000439	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—CTLA4—Behcet's disease	0.000175	0.000438	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—APOB—Behcet's disease	0.000175	0.000438	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—NOS3—Behcet's disease	0.000172	0.000431	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—CTLA4—Behcet's disease	0.000169	0.000425	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—APOB—Behcet's disease	0.000168	0.000422	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—HLA-B—Behcet's disease	0.000168	0.000422	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—ICAM1—Behcet's disease	0.000168	0.000421	CbGpPWpGaD
Ruxolitinib—PRKCE—GPCR downstream signaling—CXCL8—Behcet's disease	0.000167	0.000419	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—ICAM1—Behcet's disease	0.000165	0.000415	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—SERPINE1—Behcet's disease	0.000163	0.000409	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—CXCL8—Behcet's disease	0.000162	0.000407	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—APOA1—Behcet's disease	0.00016	0.000401	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—NOS3—Behcet's disease	0.000156	0.00039	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—CXCL8—Behcet's disease	0.000153	0.000383	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by GPCR—CXCL8—Behcet's disease	0.000152	0.00038	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—SERPINE1—Behcet's disease	0.000151	0.000379	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CCR1—Behcet's disease	0.000145	0.000364	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—NOS3—Behcet's disease	0.000144	0.000362	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—ICAM1—Behcet's disease	0.000142	0.000357	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—APOB—Behcet's disease	0.000142	0.000357	CbGpPWpGaD
Ruxolitinib—JAK3—GPCR downstream signaling—CXCL8—Behcet's disease	0.000141	0.000354	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—APOA1—Behcet's disease	0.000138	0.000347	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—CXCL8—Behcet's disease	0.000138	0.000346	CbGpPWpGaD
Ruxolitinib—JAK1—Developmental Biology—TNF—Behcet's disease	0.000136	0.000341	CbGpPWpGaD
Ruxolitinib—ROCK1—Developmental Biology—TNF—Behcet's disease	0.000134	0.000336	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—APOA1—Behcet's disease	0.000133	0.000334	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—HLA-B—Behcet's disease	0.000133	0.000334	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CTLA4—Behcet's disease	0.000132	0.000332	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—HLA-B—Behcet's disease	0.000129	0.000324	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—APOB—Behcet's disease	0.000129	0.000323	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—CXCL8—Behcet's disease	0.000128	0.000321	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—SERPINE1—Behcet's disease	0.000127	0.000318	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—HLA-B—Behcet's disease	0.000125	0.000314	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—APOB—Behcet's disease	0.000122	0.000307	CbGpPWpGaD
Ruxolitinib—JAK1—GPCR downstream signaling—CXCL8—Behcet's disease	0.000121	0.000304	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—NOS3—Behcet's disease	0.000121	0.000304	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—APOB—Behcet's disease	0.00012	0.000302	CbGpPWpGaD
Ruxolitinib—ROCK1—GPCR downstream signaling—CXCL8—Behcet's disease	0.000119	0.000299	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—APOA1—Behcet's disease	0.000112	0.000282	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—CXCL8—Behcet's disease	0.00011	0.000276	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—SERPINE1—Behcet's disease	0.00011	0.000275	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—CXCL8—Behcet's disease	0.000108	0.000272	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—ICAM1—Behcet's disease	0.000108	0.000271	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—SERPINE1—Behcet's disease	0.000106	0.000265	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—ICAM1—Behcet's disease	0.000105	0.000263	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—NOS3—Behcet's disease	0.000105	0.000263	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—APOA1—Behcet's disease	0.000102	0.000256	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—ICAM1—Behcet's disease	0.000102	0.000255	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—NOS3—Behcet's disease	0.000101	0.000253	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—TNF—Behcet's disease	0.000101	0.000252	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—HLA-B—Behcet's disease	9.79e-05	0.000246	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—APOB—Behcet's disease	9.77e-05	0.000245	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—APOA1—Behcet's disease	9.68e-05	0.000243	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—APOA1—Behcet's disease	9.52e-05	0.000239	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—APOB—Behcet's disease	9.3e-05	0.000233	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—APOB—Behcet's disease	9.03e-05	0.000226	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—CXCL8—Behcet's disease	8.96e-05	0.000225	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—SERPINE1—Behcet's disease	8.93e-05	0.000224	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—APOB—Behcet's disease	8.76e-05	0.00022	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—NOS3—Behcet's disease	8.52e-05	0.000214	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—CXCL8—Behcet's disease	8.13e-05	0.000204	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—SERPINE1—Behcet's disease	8.1e-05	0.000203	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—ICAM1—Behcet's disease	7.96e-05	0.0002	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—NOS3—Behcet's disease	7.73e-05	0.000194	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—APOA1—Behcet's disease	7.73e-05	0.000194	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—SERPINE1—Behcet's disease	7.68e-05	0.000193	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—TNF—Behcet's disease	7.62e-05	0.000191	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—CXCL8—Behcet's disease	7.56e-05	0.00019	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—SERPINE1—Behcet's disease	7.55e-05	0.000189	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—APOA1—Behcet's disease	7.36e-05	0.000185	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—NOS3—Behcet's disease	7.33e-05	0.000184	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—NOS3—Behcet's disease	7.21e-05	0.000181	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—APOA1—Behcet's disease	7.14e-05	0.000179	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—APOA1—Behcet's disease	6.93e-05	0.000174	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—APOB—Behcet's disease	6.84e-05	0.000172	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—CXCL8—Behcet's disease	6.78e-05	0.00017	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—CXCL8—Behcet's disease	6.5e-05	0.000163	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—CXCL8—Behcet's disease	6.4e-05	0.00016	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—CXCL8—Behcet's disease	6.16e-05	0.000155	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—SERPINE1—Behcet's disease	6.14e-05	0.000154	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—NOS3—Behcet's disease	5.86e-05	0.000147	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—SERPINE1—Behcet's disease	5.84e-05	0.000146	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—SERPINE1—Behcet's disease	5.67e-05	0.000142	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—NOS3—Behcet's disease	5.58e-05	0.00014	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—SERPINE1—Behcet's disease	5.5e-05	0.000138	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—APOA1—Behcet's disease	5.41e-05	0.000136	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—NOS3—Behcet's disease	5.41e-05	0.000136	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—NOS3—Behcet's disease	5.25e-05	0.000132	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—CXCL8—Behcet's disease	4.95e-05	0.000124	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CXCL8—Behcet's disease	4.8e-05	0.00012	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CXCL8—Behcet's disease	4.66e-05	0.000117	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—SERPINE1—Behcet's disease	4.3e-05	0.000108	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—NOS3—Behcet's disease	4.1e-05	0.000103	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CXCL8—Behcet's disease	3.64e-05	9.13e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CAT—Behcet's disease	2.38e-05	5.98e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—APOB—Behcet's disease	2.31e-05	5.8e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—APOA1—Behcet's disease	1.83e-05	4.59e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—NOS3—Behcet's disease	1.39e-05	3.48e-05	CbGpPWpGaD
